Malerba, A;
Klein, P;
Bachtarzi, H;
Jarmin, SA;
Cordova, G;
Ferry, A;
Strings, V;
... Dickson, G; + view all
(2017)
PABPN1 gene therapy for oculopharyngeal muscular dystrophy.
Nature Communications
, 8
, Article 14848. 10.1038/ncomms14848.
Preview |
Text
Klein_PABPN1 gene therapy for oculopharyngeal muscular dystrophy_VoR.pdf - Published Version Download (2MB) | Preview |
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles. OPMD is caused by a trinucleotide repeat expansion in the PABPN1 gene that results in an N-terminal expanded polyalanine tract in polyA-binding protein nuclear 1 (PABPN1). Here we show that the treatment of a mouse model of OPMD with an adeno-associated virus-based gene therapy combining complete knockdown of endogenous PABPN1 and its replacement by a wild-type PABPN1 substantially reduces the amount of insoluble aggregates, decreases muscle fibrosis, reverts muscle strength to the level of healthy muscles and normalizes the muscle transcriptome. The efficacy of the combined treatment is further confirmed in cells derived from OPMD patients. These results pave the way towards a gene replacement approach for OPMD treatment.
Type: | Article |
---|---|
Title: | PABPN1 gene therapy for oculopharyngeal muscular dystrophy |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/ncomms14848 |
Publisher version: | http://doi.org/10.1038/ncomms14848 |
Language: | English |
Additional information: | Copyright © The Author(s) 2017. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Structural and Molecular Biology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10070547 |
Archive Staff Only
View Item |